Methyl 5-fluorobenzo[b]thiophene-2-carboxylate, 95.0%, 5g

(S)-Tetrahydrofurfurylamine, 95.0%, 25g

2,8-Bis(diphenylphosphoryl)dibenzo[b,d]furan>96.0%(HPLC)1g

(S)-4-N-Trityl-2-methyl-piperazine, 98.0%, 5g

Adamantane, min.99%, pour la synthèse, 100 g, emballage en verre

tert-Butyl Benzoate>98.0%(GC)25mL

(4S,4'S)-4,4'-Di((S)-sec-butyl)-1,1'-bis(3-(tert-butyl)phenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 100mg

FOSTEMSAVIR, 98%, 50mg

(R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

tert-butyl 3-{[2-(morpholin-4-yl)ethyl]amino}propanoate, 95.0%, 10g

4-Amino-2-methylpyrimidine-5-carboxylic acid, 97%, 1g

Chloroethane (ca. 15% in Tetrahydrofuran, ca. 2.0mol/L)500mL

methyl 1-isopropyl-1H-pyrazole-3-carboxylate, 5g